Maximum quantity allowed is 999
请选择数量
CAS RN: 71939-50-9 | 產品號碼: D3793
產品號碼 | D3793 |
純度/分析方法 ![]() |
>98.0%(HPLC) |
分子式 / 分子量 | C__1__5H__2__4O__5 = 284.35 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Refrigerated (0-10°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Air Sensitive,Heat Sensitive |
包裝和容器 ![]() |
1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 71939-50-9 |
Reaxys-RN | 5813803 |
PubChem Substance ID | 87561556 |
SDBS (AIST Spectral DB) | 52709 |
Merck Index(14) | 817 |
MDL編號 | MFCD00274495 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC)(CAD) | min. 98.0 %(Anomeric total) |
性質
熔點 | 153 °C(dec.) |
GHS
相關法規
RTECS # | KD4165550 |
運輸資料
HS編碼* | 2932.99-000 |
Application
Dihydroartemisinin: An Active Metabolite of Antimalaria Artesunate
Dihydroartemisinin is an active metabolite of artesunate [A2191] which is a semi-synthetic derivative of artemisinin [A2118]. Dihydroartemisinin and its analogs have high efficacy against Plasmodium falciparum in the blood stages of the disease. The exact mechanism of action is still not clear, while the endoperoxide (O-O) subunit of the trioxane ring is critical for antimalarial activity. Several lines of evidence indicate that the O-O bond is easily broken by Fe2+, generating a number of reactive radicals oxidatively damage parasite. In clinical, dihydroartemisinin is often used as a combination agent with a partner agent which has a long half-life, such as piperaquine. In addition, after 2000’s, the anti-tumor activities of dihydroartemisinin have been reported. (The product is for research purpose only.)
References
- Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
- Efficacy and safety of dihydroartemisinin-piperaquine
- Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
- Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
- Development and validation of a high-performance liquid chromatography-mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma
考研文獻
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。